江西天新药业股份有限公司关于召开2025年第三季度业绩说明会的公告

Core Viewpoint - Jiangxi Tianxin Pharmaceutical Co., Ltd. is set to hold a performance briefing for the third quarter of 2025 to discuss its operational results and financial status with investors [2][3]. Group 1: Meeting Details - The performance briefing will take place on November 6, 2025, from 16:00 to 17:00 [6][7]. - The meeting will be conducted in an interactive online format via the Shanghai Stock Exchange Roadshow Center [5][6]. - Investors can participate by logging into the Shanghai Stock Exchange Roadshow Center website [5][6]. Group 2: Investor Participation - Investors can submit questions for the briefing from October 30, 2025, to November 5, 2025, by accessing the "Pre-Question Collection" section on the Shanghai Stock Exchange Roadshow Center website or via the company's email [2][8]. - The company will address commonly asked questions during the performance briefing [2][3]. Group 3: Key Personnel - Key participants in the briefing will include Mr. Yu Xiaobing (General Manager), Mr. Liu Luyao (Independent Director), Mr. Luo Xuelin (Financial Director), and Mr. Dong Yi (Board Secretary) [4].